Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections.

Joshua Osowicki ; Fergus Hamilton ; Todd C Lee ; Michael Marks ORCID logo ; Erin K McCreary ; Emily G McDonald ; Jonathan H Ryder ; Steven YC Tong ; (2024) Which trial do we need? Empiric Glycopeptides plus clindamycin versus Oxazolidinones for suspected toxic shock and necrotizing soft tissue infections. Clinical microbiology and infection, 30 (5). pp. 570-573. ISSN 1198-743X DOI: 10.1016/j.cmi.2024.02.001
Copy

picture_as_pdf
Osowicki-etal-2024-Which-trial-do-we-need.pdf
subject
Accepted Version
Available under Creative Commons: Attribution-NonCommercial-No Derivative Works 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads